Medtech companies directory 2026

Medical Device Companies in Australia

Australian hospital technology is a state-panel market with a federal ARTG number on the carton: the Therapeutic Goods Administration lists the device, and HealthShare NSW, Victorian Health, SA Health or a Queensland HHS opens the requisition that stocks the ward.

Cochlear, ResMed and Nanosonics are the Australian houses a biomedical engineer and a sleep or CSSD lead already know — implants, sleep-disordered-breathing devices, and automated disinfection. Sonic Healthcare is buyer-adjacent: a pathology network whose analyser and reagent decisions move IVD volume. Siemens, GE, Philips and Medtronic keep Sydney and Melbourne seats that bid state panels and still appoint sponsors for smaller SKUs. BioNixus fields named state panels and named LHDs, not a single “Australia hospital” TAM.

Updated September 2026 · TGA — Therapeutic Goods Administration, ARTG medical device listings as of September 2026 · 16 named accounts

Request a proposal for Australia Browse the 16 companies

TGA

Therapeutic Goods Administration — ARTG listing and sponsor duties

States

HealthShare NSW, Vic, Qld HHS and peers that open the requisition

Cochlear / ResMed

Australian-origin houses whose factories already sit in hospital and homecare briefs

MSAC

Payer-adjacent assessment path that unlocks high-cost device files

Named accounts

Top medical device companies in Australia

Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against TGA — Therapeutic Goods Administration, ARTG medical device listings (as of 2026-09-05).

#	Company	HQ	Type	Device categories	Notes
01	TGA (Therapeutic Goods Administration)	Canberra	Government	ARTG listing, sponsor licensing and post-market vigilance	The Canberra file an Australian sponsor must hold before a state-panel store will accept the SKU onto a tender shortlist.
02	HealthShare NSW / NSW Health procurement	Sydney	Government	New South Wales public-hospital panels and logistics	The densest English-speaking state door. A HealthShare NSW award does not stock a Victorian or Queensland hospital.
03	Victorian and Queensland state health procurement	Melbourne / Brisbane	Government	Vic panels and Queensland HHS buying	Two further public doors. BioNixus walks Melbourne and Brisbane as their own clocks, never as footnotes to Sydney.
04	Cochlear	Sydney	Local	Cochlear implants, bone-conduction and related hearing devices	Sydney implant house whose clinic and surgeon-preference path sits beside, not inside, a generic state-panel consumable story.
05	ResMed	Sydney / San Diego dual	Local	Sleep-disordered-breathing devices, masks and ventilation	Australian-origin sleep and ventilation book that hospital respiratory units and homecare providers already treat as a default name.
06	Nanosonics	Sydney	Local	Automated ultrasound-probe disinfection systems	CSSD installed base in public and private theatres; replacement and consumable cycles follow infection-control audits, not a one-time capital invoice.
07	Sonic Healthcare (buyer-adjacent)	Sydney	Operator	Pathology network whose analyser and reagent decisions move IVD volume	Not a device manufacturer. Central pathology purchasing is the IVD account a launch has to win after the ARTG number exists.
08	Siemens Healthineers Australia	Sydney / Melbourne	MNC	Imaging, laboratory diagnostics and radiotherapy	Teaching-hospital imaging rooms; state panels still score a service van the Sydney seat must actually staff in regional LHDs.
09	GE HealthCare Australia	Sydney	MNC	Imaging, ultrasound and monitoring	Competes with Siemens and Philips inside the same state-panel imaging rooms; LHD delegations are a second clock.
10	Medtronic Australia	Sydney / Melbourne	MNC	Cardiac, surgical, diabetes and neuromodulation	Clinical specialists cover implanting centres; many SKUs still move through a sponsor-distributor who holds the ARTG and the hospital vendor number.
11	Australian device sponsors and hospital distributors	Sydney / Melbourne / Brisbane	Distributor	ARTG sponsors, inventory and LHD last-mile for brands without a full field force	The vendor number a regional NSW or Queensland dock actually pays when the multinational seat does not invoice the ward.
12	Ramsay / Healthscope / St Vincent’s — private-group purchasing	Sydney / Melbourne	Operator	Private-hospital capital and consumable committees	Faster cycles than a state panel on some lines. A third door beside HealthShare NSW and the Queensland HHS.
13	Philips Australia (Health Systems)	Sydney	MNC	Imaging, monitoring and informatics	Monitoring and ultrasound seats in public and private rooms; state panels and private committees are different clocks.
14	SA Health / WA Health procurement	Adelaide / Perth	Government	Smaller-state public buying that Sydney-only samples miss	Further public doors. A NSW-and-Victoria-only brief is not Australia, and BioNixus will not file it as Australia.
15	MSAC (Medical Services Advisory Committee)	Canberra	Government	Payer-adjacent assessments that unlock high-cost device files	Does not raise a requisition. A favourable assessment is often what lets a state reopen a closed capital line.
16	Johnson & Johnson MedTech Australia	Sydney	MNC	Ethicon, DePuy Synthes and energy devices	Clinical-specialist plus sponsor model; a HealthShare NSW tray path is not a Ramsay tray path.

Primary research

These are the medical device companies accounts we study in Australia

Need account-level or SKU-level data for a brand in Australia? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

Planning research in Australia?

Primary research, market access & HEOR. Proposals within 48 hours.

Top pharmaceutical market research companies in Australia (2026)

How the market is structured

ARTG listing, state panel, LHD dock

A device that will be used in an Australian public hospital needs an ARTG entry held by an Australian sponsor, and a place on a state procurement panel — HealthShare NSW, Victorian Health Building Authority and HealthShare Vic vehicles, SA Health, WA Health, or a Queensland Hospital and Health Service — that the local health district will raise against. That is a different commercial object from a CE mark a Singapore hub waves at a Sydney biomedical engineer. Capital equipment is specified by the clinical stream and purchased by the state panel or the LHD/HHS when the delegation allows. NSW panels do not stock a Victorian hospital; a Queensland HHS is not HealthShare NSW. Consumables and implants ride the same panels plus specialist distributors who hold inventory in Australian warehouses. Cochlear’s implant book is a named-clinic and surgeon-preference story as much as a panel story. ResMed’s sleep and ventilation book sits in homecare and hospital respiratory units. Nanosonics’ automated disinfection installed base is a CSSD fact in public and private theatres. Sonic Healthcare, as a pathology operator, is the IVD buyer whose central decisions move reagent volume — buyer-adjacent, not a device manufacturer. Private groups (Ramsay, Healthscope, St Vincent’s) buy on committee cycles. MSAC assessments sit payer-adjacent on high-cost files. BioNixus reconstructs the named ARTG number, the named state panel and the named LHD dock before an Australia volume figure is signed.

Local

Cochlear, ResMed and Nanosonics — Australian-origin houses already on clinic, respiratory and CSSD lists — plus Sonic as the pathology buyer-adjacent account.

Cochlear
ResMed
Nanosonics

Multinational

Sydney and Melbourne multinational seats that win teaching-hospital rooms and still share regional invoices with ARTG sponsors.

Siemens Healthineers Australia
GE HealthCare Australia
Medtronic Australia
Philips Australia (Health Systems)
Johnson & Johnson MedTech Australia

Regional

Sponsors and distributors who hold the ARTG and the LHD vendor number outside the Sydney–Melbourne corridor.

Distributors & service partners

TGA as the ARTG gate, state panels as the requisition, MSAC as the payer-adjacent unlock.

TGA (Therapeutic Goods Administration)
HealthShare NSW / NSW Health procurement
Victorian and Queensland state health procurement
Sonic Healthcare (buyer-adjacent)
Australian device sponsors and hospital distributors
Ramsay / Healthscope / St Vincent’s — private-group purchasing
SA Health / WA Health procurement
MSAC (Medical Services Advisory Committee)

What is moving

What is moving the medical device market in Australia

State-panel fragmentation

HealthShare NSW, Victorian vehicles and Queensland HHS open on different calendars. A Sydney award that never reached Brisbane is a failed national launch.

ARTG sponsor hygiene

LHD stores now ask for the ARTG number on the carton; a Singapore-hub SKU without an Australian sponsor is a failed delivery.

MSAC timing on high-cost files

Implant and capital SKUs stall when the assessment lags the panel; BioNixus dates MSAC against the state envelope, not against a brochure.

Private-group committee speed

Ramsay, Healthscope and St Vincent’s will trial a SKU the public panel has not opened; mixing those clocks is the briefing error.

BioNixus fieldwork

How BioNixus studies medical device companies in Australia

The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Australia:

HealthShare NSW, Victorian and Queensland HHS panel reconstructions treated as three buyers, never as one federal warehouse.
ARTG-number traces against the carton an LHD store accepts.
Cochlear clinic and ResMed homecare interviews filed beside, not inside, state-panel consumable walks.
Sonic Healthcare pathology-buyer interviews on IVD files so the operator is not confused with a manufacturer.

Healthcare market research in Australia

Questions

Frequently Asked Questions

How are medical devices listed in Australia?

The TGA enters them on the ARTG against an Australian sponsor. Classification drives the file. A state-panel store will ask for that number on the dock.

Who buys devices for Australian public hospitals?

State procurement vehicles — HealthShare NSW, Victorian health purchasing, Queensland HHS, SA Health, WA Health — plus LHD delegations those vehicles allow.

Which Australian manufacturers belong on a brief?

Cochlear for hearing implants, ResMed for sleep and ventilation, Nanosonics for automated disinfection. Sonic Healthcare is the pathology buyer, not a manufacturer.

Does a NSW panel stock the whole country?

No. Each state is its own buyer. A HealthShare NSW award does not fill a Victorian hospital or a Queensland HHS.

What does BioNixus study on Australian device accounts?

ARTG-to-carton traces, named state-panel reconstructions, LHD versus private-group interviews, and Sonic pathology-buyer walks on IVD files.

Is this an Australian market-share ranking?

No. Names appear because they recur in BioNixus public and private hospital fieldwork; sequence is by role, not by revenue.

Sources

Data sources & methodology

This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Australia. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

Primary register: TGA — Therapeutic Goods Administration, ARTG medical device listings, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Australia, not size.

TGA ARTG and sponsor guidance, consulted 2026
HealthShare NSW, Victorian health purchasing and Queensland HHS notices
Cochlear, ResMed, Nanosonics and Sonic Healthcare published descriptions
BioNixus Australia state-panel and private-hospital fieldwork, 2023–2026

BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

48-hour proposal

Need device-level competitive data in Australia?

Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

Planning research in Australia?

Primary research, market access & HEOR. Proposals within 48 hours.

Medical Device Companies in Australia

Top medical device companies in Australia

These are the medical device companies accounts we study in Australia

Planning research in Australia?

ARTG listing, state panel, LHD dock

Local

Multinational

Regional

Distributors & service partners

What is moving the medical device market in Australia

State-panel fragmentation

ARTG sponsor hygiene

MSAC timing on high-cost files

Private-group committee speed

How BioNixus studies medical device companies in Australia

Related research and directories

More company directories for Australia

Frequently Asked Questions

Data sources & methodology

Need device-level competitive data in Australia?

Planning research in Australia?